BioSig Technologies to change name to Streamex Corp, ticker to STEX

LOS ANGELES/VANCOUVER - BioSig Technologies, Inc. (NASDAQ:BSGM) announced Wednesday it will change its name to Streamex Corp. effective Friday, September 12, 2025, following its recent merger with Streamex Exchange Corporation. The announcement comes as the company’s stock shows significant momentum, with InvestingPro data revealing a remarkable 407% surge over the past six months, despite a recent 13% decline in the past week.

The company will simultaneously change its trading symbol from BSGM to STEX on the Nasdaq Capital Market. The CUSIP number will remain unchanged, and shareholders are not required to take any action regarding the name and ticker symbol changes.

"All Company stock trading, filings, and market related information will be reported under the new symbol STEX" as of September 12, the company stated in a press release.

Streamex Exchange Corporation describes itself as a Real World Asset tokenization company focused on bringing gold and commodities markets on chain through tokenization technology.

Prior to the merger, BioSig Technologies operated as a medical device technology company with a digital signal processing platform called PURE EP, which provided insights to electrophysiologists for cardiovascular arrhythmia treatments.

The company noted that no other aspects of its corporate structure or operations will be impacted by the name and ticker symbol change beyond the rebranding.

In other recent news, BioSig Technologies, Inc. announced the completion of its underwritten public offering, raising approximately $15 million in gross proceeds. The company sold 3,852,149 shares of common stock at a price of $3.90 per share. BioSig Technologies plans to use the net proceeds from this offering to purchase gold bullion, in line with its investment policy, as well as for general corporate purposes and working capital. Additionally, BioSig Technologies’ shareholders approved an amendment to increase the number of authorized shares of common stock from 200,000,000 to 500,000,000. This amendment has been filed with the Secretary of State of Delaware and is now effective.

In another development, BioSig Technologies, through its wholly-owned subsidiary Streamex, entered a strategic partnership with Monetary Metals to develop tokenized gold products. This exclusive three-year agreement allows Streamex to tokenize Monetary Metals’ yield-bearing gold products. These recent developments highlight BioSig Technologies’ efforts to enhance its financial strategies and expand its product offerings.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.